Generally, induction of the balanced ratio of Bcl-xL/Bcl-xS has been shown anti-tumour activity by targeting multiple hallmarks of tumour, but it is still imperative that we understood this biomolecule. This evidence concerns the gene BCL2L1 and neoplasm.